Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FLUOROSCOPY X-RAY EQUIPMENT DOSE MONITORS RECOMMENDED BY FDA

This article was originally published in The Gray Sheet

Executive Summary

FLUOROSCOPY X-RAY EQUIPMENT DOSE MONITORS RECOMMENDED BY FDA to help prevent radiation overdoses during fluoroscopically-guided procedures, Bruce Burlington, director of FDA's Center for Devices and Radiological Health, told the annual meeting of the National Electrical Manufacturers Association's Diagnostic Imaging and Therapy Systems Division Sept. 19 in Edgartown, Massachusetts. FDA would like manufacturers to "incorporate equipment features which will monitor total delivered dose and make more practical the prevention of such injuries." The agency, however, currently is not planning on changing the x-ray performance standard to require dose monitors or other safety enhancements.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002854

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel